Bharat Biotech’s ‘COVAXIN’ gets approval for phase 3 trials in India
Team Udayavani, Oct 23, 2020, 9:26 AM IST
Covaxin, the coronavirus vaccine being developed by Bharat Biotech and ICMR, has received the approval by the Drugs Controller General of India (DCGI) to conduct the third phase of clinical trials.
The expert panel’s approval came after assessing data from Phases 1 and 2 along with animal trials. However, the committee suggested “minor amendments” in the protocol.
The study would cover 28,500 participants aged 18 years and above across 10 states. The Serum Institute of India began phase 3 clinical trial of Oxford vaccine last month.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Notorious gangster wanted in UAPA case arrested at Nepal border
‘Condition critical’, say doctors as farmer leader Dallewal’s fast enters 27th day
ISRO to study how crops grow in space on PSLV-C60 mission
Vandalism at Allu Arjun’s residence in Hyderabad
PM Modi to attend Christmas celebrations hosted by Catholic Bishops’ Conference of India
MUST WATCH
Latest Additions
Kannada Sahitya Sammelana: Food distribution creates stir
Rohit gets hit in nets, practice pitches on slower side
India & Kuwait elevate ties to strategic level; ink defence pact after PM Modi meets top Kuwaiti leaders
In Kuwait, PM Modi meets yoga practitioner, other influencers from Gulf country
Notorious gangster wanted in UAPA case arrested at Nepal border
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.